| Literature DB >> 27777906 |
Jun Woo Kim1, Sang Hoo Park1, Yoojin Kim1, Minji Im1, Heon-Seok Han1.
Abstract
PURPOSE: The prevalence rates of metabolic syndrome (MetS) and percentile distribution of insulin resistance (IR) among Korean children and adolescents were investigated. The cutoff values of IR were calculated to identify high-risk MetS groups.Entities:
Keywords: Adolescent; Insulin resistance; Korea; Metabolic syndrome
Year: 2016 PMID: 27777906 PMCID: PMC5073160 DOI: 10.6065/apem.2016.21.3.143
Source DB: PubMed Journal: Ann Pediatr Endocrinol Metab ISSN: 2287-1012
Fig. 1Age distribution of the participants by weighted sampling.
Criteria and definitions for metabolic syndrome in children and adolescents
| Criteria/components | Cook et al. (2003) | de Ferranti et al. (2004) | IDF (2007) |
|---|---|---|---|
| Central obesity (WC) | ≥90th percentile | ≥75th percentile | ≥90th percentile |
| Glucose | ≥110 mg/dL | ≥110 mg/dL | ≥100 mg/dL |
| BP | ≥90th percentile | ≥90th percentile | Systolic ≥ 130 mmHg |
| Diastolic ≥ 85 mmHg | |||
| Triglycerides | ≥110 mg/dL | ≥100 mg/dL | ≥150 mg/dL |
| HDL-cholesterol | ≤40 mg/dL | <50 mg/dL (girls) | <40 mg/dL |
| <45 mg/dL (boys) | |||
| Definition for MetS | Three or more among the 5 criteria | Three or more among the 5 criteria | Central obesity and the presence of 2 or more other criteria |
IDF, International Diabetes Federation; WC, waist circumference; BP, blood pressure; HDL, high density lipoprotein; MetS, metabolic syndrome.
*For adolescents older than 16 years, the IDF criteria for adults were used.
General characteristics of the participants by sex
| Characteristic | Male (n=1,756) | Female (n=1,557) |
|---|---|---|
| Age (yr) | 14.1 (14.0-14.3) | 14.1 (13.9–14.2) |
| Waist circumference (cm) | 71.8 (71.2–72.4) | 67.2 (66.6–67.7) |
| Body mass index (kg/m2) | 21.0 (20.8–21.2) | 20.1 (19.9–20.4) |
| Systolic BP (mmHg) | 106.4 (105.7–107.1) | 101.9 (101.3–102.5) |
| Diastolic BP (mmHg) | 65.9 (65.3–66.5) | 64.6 (64.0–65.2) |
| Fasting glucose (mg/dL) | 89.3 (88.9–90.0) | 88.4 (88.0–88.8) |
| HDL-cholesterol (mg/dL) | 48.3 (47.8–48.8) | 50.7 (50.1–51.3) |
| Triglyceride (mg/dL) | 86.8 (83.3–90.3) | 89.5 (86.3–92.7) |
| Metabolic syndrome (%) | ||
| Cook et al. | 4.6 (3.6–5.8) | 3.6 (2.6–4.9) |
| de Ferranti et al. | 13.9 (12.0–16.1) | 12.3 (10.5–14.4) |
| IDF | 1.4 (0.9–2.1) | 1.8 (1.2–2.7) |
Values are presented as mean (95% confidence interval).
BP, blood pressure; HDL, high density lipoprotein; IDF, International Diabetes Federation.
Clinical characteristics of the participants with metabolic syndrome by gender
| Variable | Cook et al. (2003) | de Ferranti et al. (2004) | IDF (2007) | |||
|---|---|---|---|---|---|---|
| Male (n=81) | Female (n=56) | Male (n=244) | Female (n=191) | Male (n=24) | Female (n=28) | |
| Age (yr) | 14.6 (14.1–15.1) | 13.9 (13.2–14.7) | 14.3 (14.0–14.7) | 13.5 (13.2–13.9) | 14.3 (13.4–15.2) | 14.1 (13.1–15.2) |
| WC (cm) | 87.6 (85.2–89.9) | 82.3 (80.2–84.4) | 84.6 (83.4–85.9) | 76.5 (75.2–77.7) | 95.7 (93.5–97.9) | 85.7 (83.4–88.0) |
| BMI (kg/m2) | 26.8 (25.9–27.6) | 26.0 (24.9–27.0) | 25.6 (25.1–26.0) | 23.7 (23.2–24.2) | 29.6 (28.6–30.5) | 27.3 (26.0–28.6) |
| Systolic BP (mmHg) | 116.1 (113.5–118.8) | 108.0 (105.0–111.0) | 113.4 (111.08–115.0) | 107.7 (106.4–109.0) | 117.4 (111.4–123.4) | 109.5 (105.4–113.5) |
| Diastolic BP (mmHg) | 74.8 (72.1–77.5) | 68.9 (66.1–71.8) | 71.1 (69.8–72.4) | 68.9 (67.6–70.1) | 72.9 (68.6–77.3) | 68.4 (64.5–72.2) |
| Fasting glucose (mg/dL) | 90.4 (88.9–91.8) | 92.5 (89.8–95.3) | 90.3 (89.4–91.1) | 90.2 (89.0–91.2) | 91.2 (87.4–95.0) | 95.6 (91.2–99.9) |
| HDL-cholesterol (mg/dL) | 37.7 (36.5–38.8) | 38.2 (36.6–39.7) | 39.8 (29.1–40.5) | 41.8 (40.9–42.7) | 38.0 (35.8–40.2) | 37.2 (35.5–38.8) |
| Triglyceride (mg/dL) | 184.9 (163.2–206.5) | 192.8 (150.0–235.9) | 160.8 (149.3–172.3) | 149.9 (135.8–164.0) | 219.8 (183.4–256.1) | 178.3 (156.5–200.0) |
Values are presented as mean (95% confidence interval).
WC, waist circumference; BMI, body mass index; BP, blood pressure; HDL, high density lipoprotein; IDF, International Diabetes Federation.
The distribution of the HOMA-IR and the TyG index by gender
| Variable | Mean (95% CI) | Percentile | ||||
|---|---|---|---|---|---|---|
| 10th | 25th | 50th | 75th | 90th | ||
| HOMA-IR | ||||||
| Total | 2.97 (2.90–3.04) | 1.59 | 2.06 | 2.85 | 3.45 | 4.57 |
| Male | 2.92 (2.83–3.00) | 1.55 | 2.01 | 2.58 | 3.33 | 4.51 |
| Female | 3.03 (2.93–3.13) | 1.66 | 2.12 | 2.71 | 3.54 | 4.67 |
| TyG index | ||||||
| Total | 8.13 (8.11–8.16) | 7.51 | 7.78 | 8.11 | 8.44 | 8.79 |
| Male | 8.11 (8.08–8.14) | 7.48 | 7.74 | 8.08 | 8.44 | 8.80 |
| Female | 8.15 (8.13–8.19) | 7.55 | 7.84 | 8.14 | 8.45 | 8.78 |
HOMA-IR, homeostasis model assessment of insulin resistance; TyG, triglyceride glucose; CI, confidence interval.
Fig. 2Receiver operation characteristic curves for metabolic syndrome. (A) Using the criteria of Cook et al.25), (B) using the criteria of de Ferranti et al.26), and (C) using the criteria of International Diabetes Federation27). TyG, triglyceride glucose; HOMA-IR, homeostasis model assessment of insulin resistance; AUC, area under the curve.
The proposed cutoff values of the HOMA-IR and TyG index for Korean children and adolescents according to 3 sets of criteria of metabolic syndrome
| Variable | Cook et al. | de Ferranti et al. | IDF | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Cutoff point | Sn (%) | Sp (%) | Cutoff point | Sn (%) | Sp (%) | Cutoff point | Sn (%) | Sp (%) | |
| HOMA-IR | |||||||||
| Total | 3.29 | 73.3 | 72.1 | 2.96 | 71.1 | 64.7 | 3.54 | 80.8 | 77.7 |
| Male | 2.98 | 76.5 | 66.2 | 2.86 | 71.5 | 64.2 | 3.54 | 79.2 | 79.3 |
| Female | 3.49 | 75.9 | 75.4 | 2.96 | 74.9 | 61.3 | 3.69 | 82.1 | 79.1 |
| TyG index | |||||||||
| Total | 8.48 | 95.6 | 79.9 | 8.41 | 85.0 | 80.7 | 8.66 | 90.4 | 86.4 |
| Male | 8.48 | 96.3 | 81.1 | 8.40 | 88.2 | 81.8 | 8.66 | 95.8 | 86.5 |
| Female | 8.48 | 94.4 | 78.8 | 8.38 | 85.3 | 76.3 | 8.61 | 89.3 | 84.1 |
HOMA-IR, homeostatic assessment model of insulin resistance; TyG, triglyceride glucose; IDF, International Diabetes Federation; Sn, sensitivity; Sp, specificity.